You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Wireless Enhanced Myoelectric Control to Improve Upper Extremity Amputee Ability
SBC: INFINITE BIOMEDICAL TECHNOLOGIES, LLC Topic: NICHDDESCRIPTION (provided by applicant): Wireless Enhanced Myoelectric Control to Improve Upper Extremity Amputee Ability ABSTRACT The overall goal of our research program is to enable upper extremity amputees to be productive and independent. For these individuals, one of the most promising developments in the past decade has been the introduction of fully dexterous terminal devices. However, an effe ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Virtual Role-Plays to Train Cognitive-Behavioral Treatment (CBT) for Addictions
SBC: SIMMERSION LLC Topic: NIAAA? DESCRIPTION (provided by applicant): The goal of this Phase I/Phase II fast-track application is to develop and evaluate a simulation-based product for training students and clinicians to develop the skills necessary to effectively apply Cognitive-Behavioral Treatment (CBT) with patients with substance use disorders (SUDs). CBT is one of the most common and effective treatments for SUDs; h ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Using Structuring Interacting RNAs (sxRNAs) as microRNA Inhibitors
SBC: HocusLocus Inc. Topic: NIGMSDESCRIPTION (provided by applicant): We propose developing a trans-molecular RNA-switch for scientists to negatively affect the activity of endogenous microRNA for use as a molecular tool or therapeutic, an anti-miR. Since the discovery of miRNA, the creation of effective anti-miRs has been important, first to study and verify miRNA interactions, and, secondly, as a therapeutic tool. But, creating ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
User-driven Tool for Bilingual Clinical Dialogs and Medical Language Acquisition
SBC: Transcendent International, LLC Topic: NIMHDPROJECT SUMMARY Persistent disparities in healthcare access hinder the nation's 26 million individuals with limited English proficiency (LEP) from receiving quality care and, as a result, from achieving optimal health outcomes. Patients who struggle to understand their care providers report difficulty navigating both administrative and clinical procedures and experience significantly higher r ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Ultra-low dose Influenza vaccines
SBC: Codagenix Inc. Topic: NIAIDDESCRIPTION provided by applicant Current seasonal Influenza vaccines are proving to be ineffective especially in at risk populations For example this yearandapos s inactivated flu vaccine had only a efficacy rate against H N infections in the elderly and the current live attenuated Influenza vaccine LAIV is aged restricted for those above years of age Therefore there is glaring un ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Twist-Sensor: Novel microarrays for multiplex detection of drug resistance
SBC: SCANOGEN INC. Topic: NIAIDDESCRIPTION provided by applicant Drug resistance is rapidly spreading among Gram negative bacteria seriously complicating the treatment of infected patients and increasing the risk of lethal outbreaks In particular carbapenem resistant Enterobacteriaceae CRE organisms associated with high mortality rate andgt have become prevalent worldwide During of long term acute car ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Three Dimensional Printing of Custom Foot Orthoses to Treat Flexible Flat Feet
SBC: SERAPH ROBOTICS, INC. Topic: NICHDDESCRIPTION (provided by applicant): During Phase I of this project, Seraph Robotics will complete development and initial feasibility testing of a working prototype of a specialized 3D Printer Orthosis System for creation of multi-property custom foot orthoses. The methods to be employed include the selection of materials that are of the highest quality and have appropriate properties for the sup ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic/preventive vaccination against MusPV
SBC: PAPIVAX, LLC Topic: NIAIDDESCRIPTION provided by applicant While most human papillomavirus HPV infections are short lived a subset become chronic and can progress to malignancy with much greater frequency in HIV infected individuals Only a dozen andapos high riskandapos HPV types cause cancer but HPV alone is responsible for andgt of anal cancer head and neck cancer and of cervical cancer Further and ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Technology-enhanced Tutoring: Linking School and Home to Help Struggling Readers
SBC: Sirius Thinking Ltd Topic: N/AThe project team is developing a prototype of Lightning Squad: Powered-Up Reading with Teams, a multimedia tutoring tool that will be used by paraprofessionals working with up to six 1st to 3rd grade students who need extra support in reading. The tutoring program will build on the Success for All whole school reading program through the incorporation of video segments and gaming content. The prod ...
SBIR Phase I 2014 Department of Education -
Technology Enabled Specialty Pharmacy for Oral Oncology
SBC: MedicaSafe Inc Topic: NCIDESCRIPTION (provided by applicant): This SBIR Phase I application proposes development of the MedicaSafe ChemoCareRx, a technology- enabled specialty pharmacy service for oral oncology patients built around MedicaSafe's proprietary Medication Therapy Optimization (MTO) technology. The increased use of oral oncology chemotherapy regimens has led to a paradigm shift in the treatment of cancer. ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health